Results 31 to 40 of about 58,766 (263)

Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax

open access: yesChinese Medical Journal, 2015
Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu   +10 more
doaj   +1 more source

Pleural Effusions in Hematologic Malignancies

open access: yesChest, 2004
Nearly all hematologic malignancies can occasionally present with or develop pleural effusions during the clinical course of disease. Among the most common disorders are Hodgkin and non-Hodgkin lymphomas, with a frequency of 20 to 30%, especially if mediastinal involvement is present.
Alexandrakis, MG   +3 more
openaire   +3 more sources

Surgical treatment in malignant pleural effusion

open access: yes, 2021
Malignant pleural effusion can be described as the presence of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these ...
Sahin, Ekber, Karadayi, Sule
core   +1 more source

Malignant Pleural Effusion: Diagnosis and Management [PDF]

open access: yes, 2020
Symptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options
Ferreiro Fernández, Lucía   +11 more
core   +1 more source

Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion

open access: yesTumor Biology, 2017
The differential diagnosis of malignant pleural effusion and benign pleural effusion remains a clinical problem. Reactive oxygen species modulator 1 is a novel protein overexpressed in various human tumors. The objective of this study was to evaluate the
Xianmeng Chen   +3 more
doaj   +1 more source

Management of Pleural Effusion Secondary to Malignant Mesothelioma [PDF]

open access: yes, 2021
Malignant pleural mesothelioma (MPM) is a highly aggressive pleural tumour which has been epidemiologically linked to occupational exposure to asbestos.
Alberto Aiolfi   +5 more
core   +2 more sources

Utility of Emerging Novel Criteria “Cancer Ratio” and “Cancer Ratio Plus” in Differentiating Malignant from Nonmalignant Pleural Effusions [PDF]

open access: yesIndian Journal of Respiratory Care
Background and objectives: Distinguishing between malignant and benign pleural effusion (including tuberculous pleuritis with effusion) is vital for any patient with an exudative pleural effusion.
Humaira Javaid   +5 more
doaj   +1 more source

mRNA markers associated with malignant pleural effusion

open access: yes, 2023
[[abstract]]Malignant pleural effusions (MPE) commonly result from malignant tumors and represent advanced-stage cancers. Thus, in clinical practice, early recognition of MPE is valuable.
Hsu, SC;Chang, SY;Hwang, YT;Terng, HJ;Tsai, CL;Shen, CH;Huang, SK;Chian, CF
core   +1 more source

Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions. [PDF]

open access: yesPLoS ONE, 2012
The objective of the present study was to investigate the presence of interleukin (IL)-27 in pleural effusions and to evaluate the diagnostic significance of pleural IL-27.
Wei-Bing Yang   +9 more
doaj   +1 more source

Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy

open access: yesAdvanced Science, EarlyView.
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy